A Resource Guide to Investing in Biotechnology
Directory - Encyclopedia - Stock Index - Drugs  

Biotech100 Stock Index

Eyetech Pharmaceuticals

About Eyetech

Eyetech Pharmaceuticals, Inc. is a biopharmaceutical company that specializes in the development and commercialization of novel therapeutics to treat diseases of the eye. The initial focus is on diseases affecting the back of the eye, particularly the retina.

Their most advanced product candidate is Macugen® (pegaptanib sodium injection)™ (pegaptanib sodium injection), which they are developing for the treatment of the wet form of age-related macular degeneration, known as AMD, and diabetic macular edema, known as DME. Both AMD and DME are serious diseases of the retina that can lead to severe vision loss and blindness.


Clinical Trials for Eyetech Pharmaceuticals

Two Phase 2/3 pivotal clinical trials for the use of Macugen® (pegaptanib sodium injection) in the treatment of wet AMD and a Phase 2 clinical trial of Macugen® (pegaptanib sodium injection) for the use of Macugen® (pegaptanib sodium injection) in the treatment of DME.



More on Eyetech


Home Page

Key Statistics for Eyetech

Basic Chart for Eyetech

Analyst Opinion

Analysts Estimates


Biotech100 Index
· What are the Requirements to be listed in the Biotech100 Index?
· See the Biotech100 List

Sponsored Links

Clinical Trials
· What is a Clinical Trial?
·Phase I ,-- Phase II, -- PhaseIII
·What is Randomized Control?
 What is a Double Blind Experiment?
·What is the role of the FDA?


Key Biotech Terms


Biotech Resources


Investing in Stocks
· Small Cap Stocks
· Stocks and Bonds
· Biotech100 Index

Careers and Employment
· Biotechnology and Pharmaceutical
· What are the Fastest Growing Careers?




Copyright © 2005 BIOTECH100.COM. All rights reserved.